It would have to be a huge, under the table, deal for Chan. He knows what the potential is. He's just not been in any hurry to realize it.
Part of the problem is a double edged sword. This product has so many different indications for usage. So many, on different time tracks, has been a management problem.
I think/hope they've prioritized them so the easier ones to get approval are being worked on the most.